foxo4-dri senolytic mechanism Class II senolytics inhibit survival pathways elicited by senescent Molecular targets of senolytic drugs.
Molecular targets of senolytic drugs. Download Scientific Diagram The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 an overview ScienceDirect Topics FOXO4 DRI Results: What to Expect (2026) Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


